Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fucose | 1 | 2026 | 7 | 0.940 |
Why?
|
| Congenital Disorders of Glycosylation | 1 | 2026 | 17 | 0.930 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2026 | 56 | 0.920 |
Why?
|
| Enoyl-CoA Hydratase | 1 | 2025 | 12 | 0.900 |
Why?
|
| Carnitine | 1 | 2025 | 91 | 0.860 |
Why?
|
| Weill-Marchesani Syndrome | 1 | 2013 | 1 | 0.400 |
Why?
|
| Bone Diseases, Developmental | 1 | 2013 | 16 | 0.390 |
Why?
|
| Limb Deformities, Congenital | 1 | 2013 | 22 | 0.390 |
Why?
|
| Mutation, Missense | 3 | 2019 | 335 | 0.370 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 1512 | 0.310 |
Why?
|
| Alleles | 2 | 2026 | 896 | 0.300 |
Why?
|
| Genetic Association Studies | 3 | 2023 | 371 | 0.290 |
Why?
|
| Neurofibromin 1 | 2 | 2019 | 26 | 0.280 |
Why?
|
| Neurofibromatosis 1 | 2 | 2019 | 57 | 0.270 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2023 | 229 | 0.260 |
Why?
|
| Epilepsy | 2 | 2023 | 390 | 0.230 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2026 | 42 | 0.230 |
Why?
|
| Glycosylation | 1 | 2026 | 173 | 0.220 |
Why?
|
| Dried Blood Spot Testing | 1 | 2025 | 126 | 0.200 |
Why?
|
| Biomarkers | 2 | 2026 | 4302 | 0.200 |
Why?
|
| Intellectual Disability | 2 | 2023 | 179 | 0.200 |
Why?
|
| Whole Genome Sequencing | 2 | 2021 | 178 | 0.190 |
Why?
|
| Dietary Supplements | 1 | 2026 | 584 | 0.170 |
Why?
|
| Fibroblasts | 1 | 2025 | 1028 | 0.150 |
Why?
|
| Language Disorders | 1 | 2018 | 28 | 0.140 |
Why?
|
| Speech Disorders | 1 | 2018 | 29 | 0.140 |
Why?
|
| Megalencephaly | 1 | 2018 | 20 | 0.140 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2018 | 31 | 0.140 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2018 | 11 | 0.140 |
Why?
|
| Acyltransferases | 1 | 2018 | 78 | 0.130 |
Why?
|
| Homozygote | 1 | 2018 | 199 | 0.130 |
Why?
|
| Codon | 1 | 2017 | 92 | 0.130 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2018 | 104 | 0.130 |
Why?
|
| DNA Helicases | 1 | 2018 | 136 | 0.130 |
Why?
|
| Protein Domains | 1 | 2018 | 311 | 0.120 |
Why?
|
| Precision Medicine | 1 | 2021 | 461 | 0.120 |
Why?
|
| Infant, Newborn | 2 | 2025 | 6465 | 0.110 |
Why?
|
| Developmental Disabilities | 1 | 2018 | 281 | 0.110 |
Why?
|
| Infant | 3 | 2025 | 10091 | 0.110 |
Why?
|
| Critical Illness | 1 | 2021 | 900 | 0.110 |
Why?
|
| Flow Cytometry | 1 | 2018 | 1165 | 0.100 |
Why?
|
| ADAMTS Proteins | 1 | 2013 | 5 | 0.100 |
Why?
|
| Fibrillins | 1 | 2013 | 9 | 0.100 |
Why?
|
| Fibrillin-1 | 1 | 2013 | 6 | 0.100 |
Why?
|
| Dwarfism | 1 | 2013 | 14 | 0.100 |
Why?
|
| Pathology, Molecular | 1 | 2013 | 25 | 0.100 |
Why?
|
| ADAM Proteins | 1 | 2013 | 64 | 0.100 |
Why?
|
| Female | 7 | 2026 | 79045 | 0.100 |
Why?
|
| Adipokines | 1 | 2013 | 57 | 0.100 |
Why?
|
| Genetic Variation | 1 | 2018 | 977 | 0.090 |
Why?
|
| Microfilament Proteins | 1 | 2013 | 135 | 0.090 |
Why?
|
| Point Mutation | 1 | 2013 | 241 | 0.090 |
Why?
|
| Child, Preschool | 2 | 2026 | 11868 | 0.090 |
Why?
|
| Abnormalities, Multiple | 1 | 2013 | 199 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2018 | 1166 | 0.090 |
Why?
|
| Phenotype | 4 | 2023 | 3170 | 0.090 |
Why?
|
| Humans | 10 | 2026 | 145785 | 0.080 |
Why?
|
| Male | 5 | 2026 | 73012 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 2399 | 0.080 |
Why?
|
| Heterozygote | 2 | 2019 | 314 | 0.070 |
Why?
|
| Rare Diseases | 1 | 2026 | 116 | 0.060 |
Why?
|
| GTP Phosphohydrolases | 1 | 2023 | 93 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2023 | 153 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2023 | 322 | 0.040 |
Why?
|
| California | 1 | 2021 | 473 | 0.040 |
Why?
|
| Communication | 1 | 2026 | 977 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2021 | 6033 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2021 | 324 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2019 | 302 | 0.040 |
Why?
|
| Decision Making | 1 | 2026 | 982 | 0.030 |
Why?
|
| Adenosine Triphosphatases | 1 | 2018 | 159 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2018 | 108 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2021 | 558 | 0.030 |
Why?
|
| Demography | 1 | 2017 | 282 | 0.030 |
Why?
|
| Medicaid | 1 | 2021 | 467 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 741 | 0.030 |
Why?
|
| Critical Care | 1 | 2021 | 702 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2017 | 2131 | 0.030 |
Why?
|
| Gene Expression | 1 | 2018 | 1478 | 0.020 |
Why?
|
| Genotype | 1 | 2018 | 1857 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2018 | 1599 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2017 | 1003 | 0.020 |
Why?
|
| Adult | 1 | 2013 | 40882 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 8078 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 5925 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2021 | 11794 | 0.010 |
Why?
|
| United States | 1 | 2021 | 16126 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 14254 | 0.010 |
Why?
|
| Adolescent | 1 | 2017 | 22577 | 0.010 |
Why?
|
| Child | 1 | 2017 | 22740 | 0.010 |
Why?
|